Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-27

FDA Approved: FLYRCADO — Original Application (GE Healthcare Inc.)

View source ↗

Summary

FDA approves FLYRCADO (FLURPIRIDAZ F-18) from GE Healthcare Inc. as a PET imaging radiotracer for myocardial perfusion imaging under the Original Application ND…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLYRCADO (FLURPIRIDAZ F-18)

Snippet

ORIG AP for FLYRCADO (FLURPIRIDAZ F-18)